Life-threatening intrathoracic complications during treatment with extracorporeal membrane oxygenation.
Extracorporeal membrane oxygenation (ECMO) has been successful (greater than 80% survival) in 35 centers in greater than 900 newborns with severe respiratory failure having an estimated mortality of greater than 80% on conventional management. During the last 3 years we have treated 79 newborns with 74 survivors (94%). Their diagnoses included meconium aspiration, persistent fetal circulation, respiratory distress syndrome, congenital diaphragmatic hernia, and sepsis. Seven patients (9%) had life-threatening intrathoracic complications requiring emergent intervention while on ECMO: tension hemothorax (3), tension pneumothorax (2), and pericardial tamponade (2). Pericardial tamponade and tension hemothorax and pneumothorax show a similar pathophysiology of increasing intrapericardial pressure and decreasing venous return. Perfusion is initially maintained by the nonpulsatile flow of the ECMO circuit before further decrease in venous return results in decreasing ECMO flow and progressive hemodynamic deterioration. Each of the seven patients demonstrated a clinical triad that includes increasing PaO2 and decreasing peripheral perfusion (as evidenced by decreasing pulse pressure and decreasing SvO2) followed by decreasing ECMO flow with progressive deterioration. The diagnoses were confirmed by transillumination, chest x-ray, or cardiac echocardiogram. Initial emergent placement of a percutaneous drainage catheter was temporizing in all seven cases. However, four patients required emergent thoracotomy for definitive treatment while still on ECMO. All seven patients were weaned from ECMO and are short-term survivors (6 months to 3.5 years). As use of ECMO for newborn severe respiratory failure increases, responsible physicians must be familiar with life-threatening intrathoracic complications and appropriate treatment strategies.
Zwischenberger
J B
JB
Department of Surgery, University of Texas Medical Branch, Galveston 77550.
Cilley
R E
RE
Hirschl
R B
RB
Heiss
K F
KF
Conti
V R
VR
Bartlett
R H
RH
D002305:Cardiac Tamponade / Q000209:etiology* / Q000628:therapy; D002408:Catheters, Indwelling; D005112:Extracorporeal Circulation / Q000009:adverse effects*; D006491:Hemothorax / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007231:Infant, Newborn; D010107:Oxygenators, Membrane / Q000009:adverse effects*; D011030:Pneumothorax / Q000209:etiology* / Q000628:therapy; D012127:Respiratory Distress Syndrome, Newborn / Q000628:therapy; D012189:Retrospective Studies